CONNECT WITH US
HealthTech

HealthTech

Few Americans say CDC, FDA are doing a good job: survey

Fierce Healthcare logo

Published on

Add as a preferred source on Google
Few Americans say CDC, FDA are doing a good job: survey

The American public is viewing the performance of federal health agencies as worse than ever before, with the Centers for Disease Control and Prevention in particular taking the sharpest hits in recent years, according to a recent annual poll from Gallup.

The survey, which reached 1,000 people during the first half of September, found 26% of respondents rating the CDC as doing either an “excellent” or “good” job (with other options being “only fair,” “poor” or “no opinion”). That’s a five-percentage-point decline from 2025, about 14 percentage points lower than ratings given through the COVID-19 pandemic and well below a high point of 66% back in 2017.

The Food and Drug Administration, meanwhile, scored just a hair lower this past month at 25% excellent or good job ratings. The regulator has been consistently trending below the CDC, with 27% favorable ratings in 2025, a mid-pandemic dip to 36% in 2022 and a high of 46% in 2017.

The two health agencies were graded lower than 10 others included in the poll, which was topped by the Postal Service (58%). They were also the only two agencies across the survey that received more poor ratings than excellent/good ratings, and represent the lowest points for each agency in Gallup’s historical surveys (beginning in 2003 for the CDC and 2009 for the FDA).

Both agencies have recently been on the wrong side of public headlines, Gallup noted while citing this year’s outbreaks of measles and the foodborne cyclospora . Each has also been subject to substantial upheaval and controversies under Health and Human Services Secretary Robert F.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.